The UK is represented in JPIAMR by the MRC, representing UK Research and Innovation (UKRI).
The MRC is a publicly-funded organisation dedicated to improving human health. UKRI research spans the breadth of One Health research activity including academic research and includes Innovate UK. Research into combating antimicrobial resistance is currently funded by response-mode grants, fellowships and strategic initiatives.
National AMR research program and activities
National AMR Research program
- UKRI AMR Initiative; launched 2014
- Global AMR Innovation Fund (GAMRIF); launched 2016
- Fleming Fund; launched 2016
- National PhD Training Programme in AMR; Medical Research Foundation (MRF)
- AMR Structured Operational Research and Training Initiative (AMR SORT IT); January 2019 – December 2022 NIHR with UNICEF/UNDP/ World Bank/ WHO
- UK Food Standards Agency AMR Programme
National AMR research calls
- Tackling AMR: A cross council initiative; UKRI: VMD, DHSC; 2016-2021
- Review of the impact of food processing on AMR in meat & meat products; FSA June 2018
- Burden of antimicrobial resistance genes in selected ready-to-eat foods; FSA August 2018
- Capital call to support AMR research; NIHR October 2018
- BBSRC/NERC-CONICET Joint Awards for AMR in the Environment; launched November 1st 2018
- Health Protection Research Unit in healthcare associated infections and AMR; NIHR March 2019
- UK-India tackling AMR in the environment from antimicrobial manufacturing waste; May 2019
- UK-South Africa AMR Drug Discovery Hub call; June 2019
- JPIAMR HARISSA Call -10 UK Partners/Coordinators October 2021
- BBSRC Network Plus Call: Partner with researchers in Canada to tackle AMR – June 2022
- JPIAMR Diagnostics and Surveillance Network Call 2022
- JPIAMR DRUID Call 2022
Activities on AMR actions at national level
- AMR Panel Event in Parliament; February 2019
- Tackling AMR National Campaign; March 2019
- UK-India tackling AMR in the environment from antimicrobial manufacturing waste; May 2019
- UK-South Africa AMR Drug Discovery Workshop; June 2019
- UK antibiotic procurement model launched June 2020
- Acquired carbapenemase-producing Gram-negative bacteria added to the list of organisms in the UK requiring statutory notification (July 2020).
- UK AMR Public Consultation – Webinar series Sept 2020
- Formal Inquiry: Anti-microbial resistance June 2022
- AMR Innovation Mission to the UK May 2022
- Formal Inquiry: Anti-microbial resistance June 2022
National action plans
- UK’s five-year NAP: Tackling antimicrobial resistance 2019-2024, runs until 2024 and is accompanied by a 20-year strategic vision.
- UK’s 20-year vision for AMR: Contained and Controlled; 24th January 2019
- The latest addendum to the NAP was published 16th May 2022
Management Board representative
- Carolyn Johnson, UKRI Medical Research Council
- Stephen Oakeshott, UKRI Medical Research Council
